Literature DB >> 19930045

Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.

Dilara Begum1, Masayuki Umemura, Ayano Yahagi, Yuko Okamoto, Satoru Hamada, Kiyotetsu Oshiro, Goro Matsuzaki.   

Abstract

Both CD4(+) and CD8(+) T cells are important in protection against Mycobacterium tuberculosis infection. To evaluate the effect of vaccination with Mycobacterium bovis bacille Calmette-Guérin (BCG) on the CD8(+) T-cell response to pulmonary M. tuberculosis infection, we analyzed the kinetics of CD8(+) T cells specific to the mycobacterial Mtb32a(309-318) epitope, which is shared by M. tuberculosis and M. bovis BCG, in the lung of mice infected with M. tuberculosis. The CD8(+) T cells were detected by staining lymphocytes with pentameric major histocompatibility complex (MHC) class I H-2D(b-)Mtb32a(209-318) peptide complex and were analysed by flow cytometry. Mtb32a-specific CD8(+) T cells became detectable on day 14, and reached a plateau on day 21, in the lung of M. tuberculosis-infected unvaccinated mice. Subcutaneous vaccination with M. bovis BCG in the footpads induced Mtb32a-specific CD8(+) T cells in the draining lymph nodes (LNs) on day 7 and their numbers further increased on day 14. When M. bovis BCG-vaccinated mice were exposed to pulmonaryinfection with M. tuberculosis 4 weeks after vaccination, the Mtb32a-specific CD8(+) T cells in the infected lung became detectable on day 7 and reached a plateau on day 14, which was 1 week earlier than in the unvaccinated mice. The pulmonary CD8(+) T cells from the BCG-vaccinated M. tuberculosis-infected mice produced interferon-gamma in response to Mtb32a(209-318) peptide on day 7 of the infection, whereas those of unvaccinated mice did not. The results demonstrate that induction of mycobacterial antigen-specific protective CD8(+) T cells in the M. tuberculosis-infected lung is accelerated by subcutaneous vaccination with M. bovis BCG.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19930045      PMCID: PMC2792139          DOI: 10.1111/j.1365-2567.2009.03141.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein.

Authors:  Scott M Irwin; Angelo A Izzo; Steven W Dow; Y A W Skeiky; Steven G Reed; Mark R Alderson; Ian M Orme
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection.

Authors:  Arati Kamath; Joshua S M Woodworth; Samuel M Behar
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

3.  Efficacy and applicability of mass B. C.G. vaccination in tuberculosis control.

Authors:  P D Hart
Journal:  Br Med J       Date:  1967-03-11

4.  Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.

Authors:  O Denis; E Lozes; K Huygen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms.

Authors:  A M Cooper; C D'Souza; A A Frank; I M Orme
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

6.  Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.

Authors:  Jun Wang; Michael Santosuosso; Patricia Ngai; Anna Zganiacz; Zhou Xing
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

7.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection.

Authors:  Arati B Kamath; Joshua Woodworth; Xiaowei Xiong; Chad Taylor; Yu Weng; Samuel M Behar
Journal:  J Exp Med       Date:  2004-11-22       Impact factor: 14.307

9.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  9 in total

1.  CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection.

Authors:  Tyler D Bold; Joel D Ernst
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

2.  An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.

Authors:  Mark J Cayabyab; Lizeng Qin; Suely S Kashino; Angelo Izzo; Antonio Campos-Neto
Journal:  Vaccine       Date:  2013-08-09       Impact factor: 3.641

Review 3.  Current and novel approaches to vaccine development against tuberculosis.

Authors:  Mark J Cayabyab; Lilia Macovei; Antonio Campos-Neto
Journal:  Front Cell Infect Microbiol       Date:  2012-12-06       Impact factor: 5.293

4.  Evaluation of the eukaryotic expression of mtb32C-hbha fusion gene of Mycobacterium tuberculosis in Hepatocarcinoma cell line.

Authors:  Roghayeh Teimourpour; Hosna Zare; Ramazan Rajabnia; Yousef Yahyapour; Zahra Meshkat
Journal:  Iran J Microbiol       Date:  2016-04

5.  An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice.

Authors:  Arshad Khan; Pearl Bakhru; Subramanian Dhandayuthapani; Chinnaswamy Jagannath; Sankaralingam Saikolappan; Kishore Das; Emily Soudani; Christopher R Singh; Jaymie L Estrella; Dekai Zhang; Chandrashekhar Pasare; Yue Ma; Jianjun Sun; Jin Wang; Robert L Hunter; N Tony Eissa
Journal:  NPJ Vaccines       Date:  2019-08-05       Impact factor: 7.344

6.  Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection.

Authors:  Joshua C Cyktor; Bridget Carruthers; Gillian L Beamer; Joanne Turner
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

7.  Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection.

Authors:  Ganzhu Feng; Qingtao Jiang; Mei Xia; Yanlai Lu; Wen Qiu; Dan Zhao; Liwei Lu; Guangyong Peng; Yingwei Wang
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Mycobacterium tuberculosis subverts the TLR-2-MyD88 pathway to facilitate its translocation into the cytosol.

Authors:  Aejazur Rahman; Parveen Sobia; Neeta Gupta; Luc Van Kaer; Gobardhan Das
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.

Authors:  Hazel C Poyntz; Elena Stylianou; Kristin L Griffiths; Leanne Marsay; Anna M Checkley; Helen McShane
Journal:  Tuberculosis (Edinb)       Date:  2014-01-02       Impact factor: 3.131

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.